| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992493 | Journal of Thoracic Oncology | 2008 | 10 Pages |
Abstract
The combination of TG4010 with standard chemotherapy in advanced non-small cell lung cancer is feasible and shows encouraging results. A randomized study evaluating the addition of TG4010 to first line chemotherapy in this population is in progress.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rodryg MD, PhD, Elisabeth MD, PhD, Janusz MD, PhD, Miklos MD, Herve MD, Eric MD, Maciej MD, PhD, Dagmar MD, Eric MD, Marie-Pierre MD, Jean-Marc MD, MSc, Nadine PhD, Bruce PhD, Céline PhD, Thierry MD,